Related Experiment Videos
Thymidylate Synthase Pharmacogenetics in Colorectal Cancer
1University of Texas Health Sciences Center, San Antonio, Texas.
Clinical Colorectal Cancer
|November 27, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Engineering macrophages for effective and safe targeting of CD47 cancer cells in the tumor microenvironment.
Journal for immunotherapy of cancer·2026
Oncolytic viruses targeting CD47: a new road to success?
Journal for immunotherapy of cancer·2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols.
Journal for immunotherapy of cancer·2025
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies.
Frontiers in oncology·2020
Improving attribution of adverse events in oncology clinical trials.
Cancer treatment reviews·2019
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2019
Colorectal Cancer Screening at Younger Ages: A Multicutoff Analysis of FIT Performance.
Clinical colorectal cancer·2026
Neoadjuvant Bevacizumab and Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-Term Outcomes of a Multicentre Study.
Clinical colorectal cancer·2026
The Impact of Lesion Morphology and Resection Strategy on Curative Outcomes in Colorectal Malignant Polyps.
Clinical colorectal cancer·2026
Comparing Quality of Life in Rectal Cancer Survivors Managed With Watch-and-Wait Versus Surgery.
Clinical colorectal cancer·2026
Identification of a novel small-molecule modulator targeting SNX10 to inhibit osteoclastic bone resorption.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Recurrence distance analysis for clinical target volume optimization in glioblastoma.
Clinical and translational radiation oncology·2026